Search - tctmd.com

Displaying 161 - 176 of 176

Sort: Relevancy | Date

News Industry News

Medtronic CoreValve® System Obtains Early FDA Approval

January 16, 2014

Presentation TCT 2013

Echocardiographic Results in the CoreValve US Extreme Risk Study: Hemodynamics and Aortic Regurgitation

Presenter: Jae Oh

October 29, 2013

Presentation TCT 2013

Hemodynamics and Interactive Calculations for Aortic Stenosis using the “John Madden” Telestrator

Presenter: Jeff Davis

October 27, 2013

News Daily News

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

Yael L. Maxwell

September 27, 2013

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

Presentation ECHO 2013

Hemodynamics I. Basic Calculations: SV and CO, Valve Areas and Intracardiac Pressures

Presenter: Rebecca T. Hahn

April 03, 2013

News Conference News ACC 2013

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

Yael L. Maxwell

March 11, 2013

News Daily News

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Caitlin E. Cox

January 16, 2013

Presentation TCT 2012

Aortic Valve Disease Hemodynamics and Intervention with Approved Devices (Including Related Guidelines)

Presenter: Susheel Kodali

October 22, 2012

News Daily News

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

L.A. McKeown

October 18, 2012

News Daily News

Persistent Left Bundle Branch Block after TAVR Linked to Ventricular Dysfunction

October 04, 2012

News Conference News ESC 2012

French, European Registries Add International Flavor to TAVR Assessment

August 29, 2012

Presentation TVT 2012

Transcatheter Treatment of LVAD-associated Aortic Regurgitation

Presenter: 136460|Atman Shah

June 02, 2012

News Conference News ACC 2012

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

March 26, 2012

CME

Low-Risk Patients: The Changing Face of TAVR

CME

Advertisement

Medtronic CoreValve® System Obtains Early FDA Approval

Echocardiographic Results in the CoreValve US Extreme Risk Study: Hemodynamics and Aortic Regurgitation

Hemodynamics and Interactive Calculations for Aortic Stenosis using the “John Madden” Telestrator

Meta-analysis: Women Fare Better Than Men After TAVR Despite More Complications

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Hemodynamics I. Basic Calculations: SV and CO, Valve Areas and Intracardiac Pressures

PARTNER: TAVR Still Safe, Effective at 3 Years, Stroke Risk Diminished

European Registry: TAVR Devices Show Similar Short-, Long-term Outcomes

Aortic Valve Disease Hemodynamics and Intervention with Approved Devices (Including Related Guidelines)

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

Persistent Left Bundle Branch Block after TAVR Linked to Ventricular Dysfunction

French, European Registries Add International Flavor to TAVR Assessment

Transcatheter Treatment of LVAD-associated Aortic Regurgitation

PARTNER: TAVR Remains as Effective as Surgery at 2 Years

Low-Risk Patients: The Changing Face of TAVR

Aortic Stenosis, TAVR, ViV-TAVR: Peri-procedural Hemodynamics

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content